Skip to main content

Table 3 Six-month clinical and health economic outcomes

From: The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial

6-month clinical and health economic outcomes

Control group mean (95% confidence interval ), n

Intervention group mean (95% confidence interval ), n

Chalder Fatigue score

14.7 (10.6, 18.9), 16

12.3 (9.3, 15.3), 20

Pain VAS

18.9 (5.8, 31.9), 16

22.1 (8.5, 35.7), 19

SF-36 physical function score

84.4 (72.4, 96.3), 16

76.8 (65.1, 88.4), 20

HADS Anxiety score

7.8 (4.9, 10.6), 16

7.8 (5.4, 10.3), 19

HADS Depression score

4.6 (2.9, 6.2), 16

4.9 (3.0, 6.9), 19

EQ-5D-5L score

0.77 (0.677, 0.870), 16

0.749 (0.643, 0.855), 19

h missed from work due to health problems in the past 7 days

1.8 (− 0.4, 4.1), 11

5.3 (− 2.5, 13.1), 15

Health problems affected productivity while working in the past 7 days

3.0 (1.6, 4.4), 12

1.8 (0.6, 3.0), 13

QALY

Control group AUC (SD) (n= 16)

Intervention group AUC (SD) (n= 20)

0.371 (0.326, 0.416)

0.346 (0.293, 0.400)